Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis

Clinical and Experimental Rheumatology

Volumn 23, Issue 1, 2005, Pages 50-56

  Ponyi, Andrea ^a,b   Constantin, T ^a   Balogh, Z ^c   Szalai, Z ^d   Borgulya, G ^a   Molnar K ^d   Tefner, I ^c   Garami, M ^a   Fekete, G ^b   Danko K ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^d HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

Author keywords

Disease course; Juvenile and adult dermatomyositis; Relapse risk; Survival analysis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RITROSULFAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEATH; DERMATOMYOSITIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYOSITIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNGARY; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 20144384248     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ADAMS EM, PLOTZ PH: The treatment of myositis. How to approach resistant disease. Rheum Dis Clin North Am 1995; 21: 179-202.
2. AL-MAYOUF S, AL-MAZYED A, BAHARBI S: Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheumatol 2000; 19: 138-41.
3. BOHAN A, PETER BJ: Polymyositis and dermatomyositis. Parts 1 and 2. New Eng J Med 1975; 292: 344-7, 403-7.
4. FISLER RE, LIANG MG, FUHLBRIGGE RC, YALCINDAG A, SUNDEL RP: Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002; 47: 505-11.
5. HOCHBERG MC: Epidemiology of polymyositis/dermatomyositis. Mount Sinai J Med 1988; 55: 447-52.
6. HUBER AM, LANG B, LeBLANC CMA et al.: Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 43: 541-9.
7. LOVE LA, LEFF RL, FRASER DD et al.: A new approach to the classification of the idiopathic inflammatory myopathy: myositis specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 360-74.
8. LUNDBERG I, CHUNG YL: Treatment and investigation of idiopathic inflammatory myopathies. Rheumatol 2000; 39: 7-17.
9. MARIE I, HACHULLA E, HATRON P-Y et al.: Polymyositis and drematomyositis: short term and long term outcome, and predicitve factors of prognosis. J Rheumatol 2001; 28: 2230-7.
10. MILLER LC, SISSON BA, TUCKER LB, deNARDO BA, SCHALLER JG: Methotrexate treatment of recalcitrant childhood dermatomyositis. Arthritis Rheum 1992; 35: 1143-9.
11. MOSCA M, NERI R, PASERO G, BOMBARDIERI S: Treatment of the idiopathic inflammatory myopathies: A retrospective analysis of 63 Caucasian patients longitudinally followed at a single center. Clin Exp Rheumatol 2000; 18: 451-6.
12. PHILLIPS BA, ZILKO P, GARLEPP MJ, MASTAGLIA FL: Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle Nerve 1998; 21: 1668-72.
13. PLOTZ PH, RIDER LG, TARGOFF IN et al.: NIH Conference, Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995; 122: 715-24.
14. POTAIN CE: Morve chronique de forme anomale. Bull Soc Hop Paris 1875; 12: 314.
15. REED AM, LOPEZ M: Juvenile dermatomyositis - recognition and treatment. Pediatr Drugs 2002; 4: 315-21.
16. RIDER LG, MILLER FW: Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 1997; 23: 619-55.
17. SPIERA R, KAGEN L: Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol 1998; 10: 556-61.
18. SULTAN SM, IOANNOU Y, MOSS K, ISENBERG DA: Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 2002; 41: 22-6.
19. VILLALBA L, ADAMS EM: Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 1996; 8: 544-51.
20. ZELLER V, COHEN P, PRIEUR AM et al.: Cyclosporin A therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. J Rheumatol 1996; 23: 1424-7.